White House Scraps Medicare Drug Rebate Rule

Drug Industry Daily
A A
The Trump Administration has withdrawn a proposed rule targeting “backdoor” rebates between drugmakers and pharmacy benefit managers (PBMs).

To View This Article:

Login

Subscribe To Drug Industry Daily